Organic compounds showing the ability to inhibit Botulinum neurotoxin activity are disclosed. The disclosed Botulinum neurotoxin inhibitor compounds are useful for treating, preventing, or reducing the intoxication of Botulinum neurotoxin, particularly Botulinum neurotoxin A and/or B.
